September 15, 2021 Four-time NYC Marathoner Amy Cargain is taking on the challenge once again this year because every mile helps raise awareness for lupus and lupus research. And for Amy, the Lupus Research Alliance was her number one charity to run for. “The LRA is home to me, and the staff is like family. […] READ MORE
September 2, 2021 The United Nations designated September 5 as the annual International Day of Charity to urge people worldwide to help others through volunteer and philanthropic activities. The Lupus Research Alliance is happy to join groups around the world in acknowledging this important yearly observance. We are very proud to be recognized by several independent charity watchdog organizations that monitor and encourage […] READ MORE
August 24, 2021 We give a big thank you to the Lupus and Allied Diseases Association, Inc. (LADA) for their generous donation of $120,000 to support research funded by the Lupus Research Alliance. The funding is specifically directed to Dr. Zahi Touma at University of Toronto for his Modeling Cognitive Impairment project and Dr. Joyce Chang at Boston Children’s […] READ MORE
August 18, 2021 Many lupus patients are at risk for COVID-19 infection because of treatment with corticosteroids and other immunosuppressive medications and will be eligible for booster vaccination. However, there are large gaps in our understanding of who will benefit from the booster vaccines, what strategies will improve response to the vaccine and the best […] READ MORE
August 13, 2021 – 4:45 PM The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices voted unanimously to recommend, and CDC Director Rochelle Walensky, MD subsequently approved, that people with moderately to severely weakened immune systems receive a third dose of the COVID-19 Pfizer or Moderna vaccines. The CDC defined the […] READ MORE
August 13, 2021 As you have probably heard on the news, the U.S. Food and Drug Administration granted late last night Emergency Use Authorization of a booster third dose of the Pfizer and Moderna COVID-19 vaccine for “some people who are immunocompromised — specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered […] READ MORE
August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given that the Moderna and Pfizer vaccines are the first mRNA vaccines currently authorized for the emergency use in people, lupus researchers have since worked to answer questions specifically about potential side effects and whether these […] READ MORE
Research Funded by the Lupus Research Alliance Published in Today’s “Cell” NEW YORK, NY August 11, 2021. Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in New York identified problems in the red blood cells of children with active Systemic Lupus […] READ MORE
August 2, 2021 Dear Friend of the Lupus Research Alliance, As we reported this morning, the lupus community has much to celebrate with the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (brand name, Saphnelo™). As a first-in-class and only new treatment for systemic lupus erythematosus in a decade, this approval marks a major […] READ MORE
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] READ MORE
July 29, 2021 A new study showed that people with lupus experienced significant physical and emotional effects in the early months of the COVID-19 pandemic. Including LRA Scientific Advisory Board member Jane Salmon, MD, researchers at Hospital for Special Surgery and Tufts University in Boston invited 97 patients to complete a questionnaire in the […] READ MORE
August 5, 2021 Researchers at St. Jude Children’s Research Hospital identified the series of molecules that guide a sub-set of immune cells, which may be key for future vaccine improvements and autoimmune therapies. These findings, published online July 7, 2021 in Nature, were funded in part by the Lupus Research Alliance (LRA). The immune system […] READ MORE
